In colorectal adenocarcinoma, higher expression levels of PRKAA1, PRKAA2, PRKAB1, and PRKAB2 are associated with improved overall survival compared to lower expression levels [77], suggesting that the expression of the aforementioned genes is dependent on both the tumor type and the biological context. This evidence concerns the gene PRKAA2 and colorectal adenocarcinoma.